Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

CE: Original Research: Advance Care Planning: An Exploration of the Beliefs, Self-Efficacy, Education, and Practices of RNs and LPNs.

Ludwick R, Baughman KR, Jarjoura D, Kropp DJ.

Am J Nurs. 2018 Dec;118(12):26-32. doi: 10.1097/01.NAJ.0000549664.43827.ce.

PMID:
30418182
2.

Angiotensin Receptor Expression and Vascular Endothelial Dysfunction in Obstructive Sleep Apnea.

Khayat RN, Varadharaj S, Porter K, Sow A, Jarjoura D, Gavrilin MA, Zweier JL.

Am J Hypertens. 2018 Feb 9;31(3):355-361. doi: 10.1093/ajh/hpx174.

3.

Advance Care Planning in Skilled Nursing Facilities: A Multisite Examination of Professional Judgments.

Baughman KR, Ludwick R, Jarjoura D, Kropp D, Shenoy V.

Gerontologist. 2019 Mar 14;59(2):338-346. doi: 10.1093/geront/gnx129.

PMID:
28958015
4.

Luteal versus follicular phase surgical oophorectomy plus tamoxifen in premenopausal women with metastatic hormone receptor-positive breast cancer.

Love RR, Hossain SM, Hussain MM, Mostafa MG, Laudico AV, Siguan SS, Adebamowo C, Sun JZ, Fei F, Shao ZM, Liu Y, Akram Hussain SM, Zhang B, Cheng L, Panigaro S, Walta F, Chuan JH, Mirasol-Lumague MR, Yip CH, Navarro NS Jr, Huang CS, Lu YS, Ferdousy T, Salim R, Akhter C, Nahar S, Uy G, Young GS, Hade EM, Jarjoura D.

Eur J Cancer. 2016 Jun;60:107-16. doi: 10.1016/j.ejca.2016.03.011. Epub 2016 Apr 20.

5.

NK Cell-Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin Are Enhanced by Cytokines.

Jaime-Ramirez AC, McMichael E, Kondadasula S, Skinner CC, Mundy-Bosse BL, Luedke E, Jones NB, Mani A, Roda J, Karpa V, Li H, Li J, Elavazhagan S, La Perle KM, Schmitt AC, Lu Y, Zhang X, Pan X, Mao H, Davis M, Jarjoura D, Butchar JP, Poi M, Phelps M, Tridandapani S, Byrd JC, Caligiuri MA, Lee RJ, Carson WE 3rd.

Cancer Immunol Res. 2016 Apr;4(4):323-336. doi: 10.1158/2326-6066.CIR-15-0168. Epub 2016 Feb 10.

6.

Options and Considerations for Adaptive Laboratory Experiments.

Wei L, Jarjoura D.

Stat Biosci. 2015 Oct 1;7(2):348-366. Epub 2014 Nov 25.

7.

Timing of adjuvant surgical oophorectomy in the menstrual cycle and disease-free and overall survival in premenopausal women with operable breast cancer.

Love RR, Laudico AV, Van Dinh N, Allred DC, Uy GB, Quang le H, Salvador JD, Siguan SS, Mirasol-Lumague MR, Tung ND, Benjaafar N, Navarro NS Jr, Quy TT, De La Peña AS, Dofitas RB, Bisquera OC Jr, Linh ND, To TV, Young GS, Hade EM, Jarjoura D.

J Natl Cancer Inst. 2015 Mar 19;107(6):djv064. doi: 10.1093/jnci/djv064. Print 2015 Jun.

8.

Sleep disordered breathing and post-discharge mortality in patients with acute heart failure.

Khayat R, Jarjoura D, Porter K, Sow A, Wannemacher J, Dohar R, Pleister A, Abraham WT.

Eur Heart J. 2015 Jun 14;36(23):1463-9. doi: 10.1093/eurheartj/ehu522. Epub 2015 Jan 29.

9.

Endothelial nitric oxide synthase uncoupling: a novel pathway in OSA induced vascular endothelial dysfunction.

Varadharaj S, Porter K, Pleister A, Wannemacher J, Sow A, Jarjoura D, Zweier JL, Khayat RN.

Respir Physiol Neurobiol. 2015 Feb 1;207:40-7. doi: 10.1016/j.resp.2014.12.012. Epub 2014 Dec 19.

10.

Follicular thyroid cancers demonstrate dual activation of PKA and mTOR as modeled by thyroid-specific deletion of Prkar1a and Pten in mice.

Pringle DR, Vasko VV, Yu L, Manchanda PK, Lee AA, Zhang X, Kirschner JM, Parlow AF, Saji M, Jarjoura D, Ringel MD, La Perle KM, Kirschner LS.

J Clin Endocrinol Metab. 2014 May;99(5):E804-12. doi: 10.1210/jc.2013-3101. Epub 2014 Feb 10.

11.

Bone mineral density following surgical oophorectomy and tamoxifen adjuvant therapy for breast cancer.

Love RR, Young GS, Laudico AV, Van Dinh N, Uy GB, Quang le H, De La Peña AS, Dofitas RB, Bisquera OC Jr, Siguan SS, Salvador JD, Mirasol-Lumague MR, Navarro NS Jr, Linh ND, Jarjoura D.

Cancer. 2013 Nov 1;119(21):3746-52. doi: 10.1002/cncr.28302. Epub 2013 Aug 20.

12.

Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies.

Rafiq S, Siadak A, Butchar JP, Cheney C, Lozanski G, Jacob NK, Lapalombella R, McGourty J, Moledor M, Lowe R, Setter B, Jones J, Flynn JM, Andritsos L, Devine S, Mo X, Jarjoura D, Tridandapani S, Algate P, Byrd JC, Muthusamy N.

MAbs. 2013 Sep-Oct;5(5):723-35. doi: 10.4161/mabs.25282. Epub 2013 Jun 7.

13.

Targeted drug delivery and cross-linking induced apoptosis with anti-CD37 based dual-ligand immunoliposomes in B chronic lymphocytic leukemia cells.

Yu B, Mao Y, Yuan Y, Yue C, Wang X, Mo X, Jarjoura D, Paulaitis ME, Lee RJ, Byrd JC, Lee LJ, Muthusamy N.

Biomaterials. 2013 Aug;34(26):6185-93. doi: 10.1016/j.biomaterials.2013.04.063. Epub 2013 May 28.

14.

Development of p21 activated kinase-targeted multikinase inhibitors that inhibit thyroid cancer cell migration.

Ma Y, McCarty SK, Kapuriya NP, Brendel VJ, Wang C, Zhang X, Jarjoura D, Saji M, Chen CS, Ringel MD.

J Clin Endocrinol Metab. 2013 Aug;98(8):E1314-22. doi: 10.1210/jc.2012-3937. Epub 2013 May 24. Erratum in: J Clin Endocrinol Metab. 2016 Mar;101(3):1314.

15.

Toward personalized therapy in AML: in vivo benefit of targeting aberrant epigenetics in MLL-PTD-associated AML.

Bernot KM, Siebenaler RF, Whitman SP, Zorko NA, Marcucci GG, Santhanam R, Ahmed EH, Ngangana M, McConnell KK, Nemer JS, Brook DL, Kulp SK, Chen CS, Frankhouser D, Yan P, Bundschuh R, Zhang X, Dorrance AM, Dickerson KE, Jarjoura D, Blum W, Marcucci G, Caligiuri MA.

Leukemia. 2013 Dec;27(12):2379-82. doi: 10.1038/leu.2013.147. Epub 2013 May 10. No abstract available.

16.

The proteasome inhibitor carfilzomib functions independently of p53 to induce cytotoxicity and an atypical NF-κB response in chronic lymphocytic leukemia cells.

Gupta SV, Hertlein E, Lu Y, Sass EJ, Lapalombella R, Chen TL, Davis ME, Woyach JA, Lehman A, Jarjoura D, Byrd JC, Lucas DM.

Clin Cancer Res. 2013 May 1;19(9):2406-19. doi: 10.1158/1078-0432.CCR-12-2754. Epub 2013 Mar 20.

17.

Toll-like receptor 2 ligands regulate monocyte Fcγ receptor expression and function.

Shah P, Fatehchand K, Patel H, Fang H, Justiniano SE, Mo X, Jarjoura D, Tridandapani S, Butchar JP.

J Biol Chem. 2013 Apr 26;288(17):12345-52. doi: 10.1074/jbc.M113.449983. Epub 2013 Mar 15.

18.

CYP2D6 genotypes, endoxifen levels, and disease recurrence in 224 Filipino and Vietnamese women receiving adjuvant tamoxifen for operable breast cancer.

Love RR, Desta Z, Flockhart D, Skaar T, Ogburn ET, Ramamoorthy A, Uy GB, Laudico AV, Van Dinh N, Quang le H, Van To T, Young GS, Hade E, Jarjoura D.

Springerplus. 2013 Dec;2(1):52. doi: 10.1186/2193-1801-2-52. Epub 2013 Feb 15.

19.

Modulation of sodium/iodide symporter expression in the salivary gland.

La Perle KM, Kim DC, Hall NC, Bobbey A, Shen DH, Nagy RS, Wakely PE Jr, Lehman A, Jarjoura D, Jhiang SM.

Thyroid. 2013 Aug;23(8):1029-36. doi: 10.1089/thy.2012.0571. Epub 2013 Jul 17.

20.

Comparative assessment of clinically utilized CD20-directed antibodies in chronic lymphocytic leukemia cells reveals divergent NK cell, monocyte, and macrophage properties.

Rafiq S, Butchar JP, Cheney C, Mo X, Trotta R, Caligiuri M, Jarjoura D, Tridandapani S, Muthusamy N, Byrd JC.

J Immunol. 2013 Mar 15;190(6):2702-11. doi: 10.4049/jimmunol.1202588. Epub 2013 Feb 15.

21.

Massage timing affects postexercise muscle recovery and inflammation in a rabbit model.

Haas C, Butterfield TA, Abshire S, Zhao Y, Zhang X, Jarjoura D, Best TM.

Med Sci Sports Exerc. 2013 Jun;45(6):1105-12. doi: 10.1249/MSS.0b013e31827fdf18.

22.

Milatuzumab-conjugated liposomes as targeted dexamethasone carriers for therapeutic delivery in CD74+ B-cell malignancies.

Mao Y, Triantafillou G, Hertlein E, Towns W, Stefanovski M, Mo X, Jarjoura D, Phelps M, Marcucci G, Lee LJ, Goldenberg DM, Lee RJ, Byrd JC, Muthusamy N.

Clin Cancer Res. 2013 Jan 15;19(2):347-56. doi: 10.1158/1078-0432.CCR-12-2046. Epub 2012 Dec 3.

23.

Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia.

Yu B, Mao Y, Bai LY, Herman SE, Wang X, Ramanunni A, Jin Y, Mo X, Cheney C, Chan KK, Jarjoura D, Marcucci G, Lee RJ, Byrd JC, Lee LJ, Muthusamy N.

Blood. 2013 Jan 3;121(1):136-47. doi: 10.1182/blood-2012-01-407742. Epub 2012 Nov 19.

24.

Workplace based mindfulness practice and inflammation: a randomized trial.

Malarkey WB, Jarjoura D, Klatt M.

Brain Behav Immun. 2013 Jan;27(1):145-54. doi: 10.1016/j.bbi.2012.10.009. Epub 2012 Oct 16.

25.

Use of the hollow fiber assay for the discovery of novel anticancer agents from fungi.

Pearce CJ, Lantvit DD, Shen Q, Jarjoura D, Zhang X, Oberlies NH, Kroll DJ, Wani MC, Orjala J, Soejarto DD, Farnsworth NR, de Blanco EJ, Fuchs JR, Kinghorn AD, Swanson SM.

Methods Mol Biol. 2012;944:267-77. doi: 10.1007/978-1-62703-122-6_20.

PMID:
23065624
26.

Chemical Diversity of Metabolites from Fungi, Cyanobacteria, and Plants Relative to FDA-Approved Anticancer Agents.

El-Elimat T, Zhang X, Jarjoura D, Moy FJ, Orjala J, Kinghorn AD, Pearce CJ, Oberlies NH.

ACS Med Chem Lett. 2012 Jul 12;3(8):645-649.

27.

Pharmacokinetics and tissue disposition of lenalidomide in mice.

Rozewski DM, Herman SE, Towns WH 2nd, Mahoney E, Stefanovski MR, Shin JD, Yang X, Gao Y, Li X, Jarjoura D, Byrd JC, Johnson AJ, Phelps MA.

AAPS J. 2012 Dec;14(4):872-82. doi: 10.1208/s12248-012-9401-2. Epub 2012 Sep 7.

28.

A scoring system for the prognosis and treatment of malignant bowel obstruction.

Henry JC, Pouly S, Sullivan R, Sharif S, Klemanski D, Abdel-Misih S, Arradaza N, Jarjoura D, Schmidt C, Bloomston M.

Surgery. 2012 Oct;152(4):747-56; discussion 756-7. doi: 10.1016/j.surg.2012.07.009. Epub 2012 Aug 26.

29.

Dual targeting of the cyclin/Rb/E2F and mitochondrial pathways in mantle cell lymphoma with the translation inhibitor silvestrol.

Alinari L, Prince CJ, Edwards RB, Towns WH, Mani R, Lehman A, Zhang X, Jarjoura D, Pan L, Kinghorn AD, Grever MR, Baiocchi RA, Lucas DM.

Clin Cancer Res. 2012 Sep 1;18(17):4600-11. doi: 10.1158/1078-0432.CCR-12-0839. Epub 2012 Jul 12.

30.

Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure.

Khayat R, Abraham W, Patt B, Brinkman V, Wannemacher J, Porter K, Jarjoura D.

J Card Fail. 2012 Jul;18(7):534-40. doi: 10.1016/j.cardfail.2012.05.003.

31.

Dose-dependency of massage-like compressive loading on recovery of active muscle properties following eccentric exercise: rabbit study with clinical relevance.

Haas C, Butterfield TA, Zhao Y, Zhang X, Jarjoura D, Best TM.

Br J Sports Med. 2013 Jan;47(2):83-8. doi: 10.1136/bjsports-2012-091211. Epub 2012 Jun 26.

PMID:
22736207
32.

Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemias.

Zorko NA, Bernot KM, Whitman SP, Siebenaler RF, Ahmed EH, Marcucci GG, Yanes DA, McConnell KK, Mao C, Kalu C, Zhang X, Jarjoura D, Dorrance AM, Heerema NA, Lee BH, Huang G, Marcucci G, Caligiuri MA.

Blood. 2012 Aug 2;120(5):1130-6. doi: 10.1182/blood-2012-03-415067. Epub 2012 Jun 6.

33.

Tetraspanin CD37 directly mediates transduction of survival and apoptotic signals.

Lapalombella R, Yeh YY, Wang L, Ramanunni A, Rafiq S, Jha S, Staubli J, Lucas DM, Mani R, Herman SE, Johnson AJ, Lozanski A, Andritsos L, Jones J, Flynn JM, Lannutti B, Thompson P, Algate P, Stromatt S, Jarjoura D, Mo X, Wang D, Chen CS, Lozanski G, Heerema NA, Tridandapani S, Freitas MA, Muthusamy N, Byrd JC.

Cancer Cell. 2012 May 15;21(5):694-708. doi: 10.1016/j.ccr.2012.03.040.

34.

Thyroid-specific ablation of the Carney complex gene, PRKAR1A, results in hyperthyroidism and follicular thyroid cancer.

Pringle DR, Yin Z, Lee AA, Manchanda PK, Yu L, Parlow AF, Jarjoura D, La Perle KM, Kirschner LS.

Endocr Relat Cancer. 2012 May 24;19(3):435-46. doi: 10.1530/ERC-11-0306. Print 2012 Jun.

35.

XmAb-5574 antibody demonstrates superior antibody-dependent cellular cytotoxicity as compared with CD52- and CD20-targeted antibodies in adult acute lymphoblastic leukemia cells.

Rafiq S, Cheney C, Mo X, Jarjoura D, Muthusamy N, Byrd JC.

Leukemia. 2012 Jul;26(7):1720-2. doi: 10.1038/leu.2012.40. Epub 2012 Feb 15. No abstract available.

36.

Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro.

Koh YW, Shah MH, Agarwal K, McCarty SK, Koo BS, Brendel VJ, Wang C, Porter K, Jarjoura D, Saji M, Ringel MD.

Endocr Relat Cancer. 2012 Jan 9;19(1):29-38. doi: 10.1530/ERC-11-0155. Print 2012 Feb.

37.

AP-1 elements and TCL1 protein regulate expression of the gene encoding protein tyrosine phosphatase PTPROt in leukemia.

Motiwala T, Zanesi N, Datta J, Roy S, Kutay H, Checovich AM, Kaou M, Zhong Y, Johnson AJ, Lucas DM, Heerema NA, Hagan J, Mo X, Jarjoura D, Byrd JC, Croce CM, Jacob ST.

Blood. 2011 Dec 1;118(23):6132-40. doi: 10.1182/blood-2011-01-323147. Epub 2011 Oct 14.

38.

LyGDI, a novel SHIP-interacting protein, is a negative regulator of FcγR-mediated phagocytosis.

Mehta P, Wavreille AS, Justiniano SE, Marsh RL, Yu J, Burry RW, Jarjoura D, Eubank T, Caligiuri MA, Butchar JP, Tridandapani S.

PLoS One. 2011;6(6):e21175. doi: 10.1371/journal.pone.0021175. Epub 2011 Jun 14.

39.

Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1/P-glycoprotein overexpression in acute lymphoblastic leukemia cells.

Gupta SV, Sass EJ, Davis ME, Edwards RB, Lozanski G, Heerema NA, Lehman A, Zhang X, Jarjoura D, Byrd JC, Pan L, Chan KK, Kinghorn AD, Phelps MA, Grever MR, Lucas DM.

AAPS J. 2011 Sep;13(3):357-64. doi: 10.1208/s12248-011-9276-7. Epub 2011 May 4.

40.

Akt1 deficiency delays tumor progression, vascular invasion, and distant metastasis in a murine model of thyroid cancer.

Saji M, Narahara K, McCarty SK, Vasko VV, La Perle KM, Porter K, Jarjoura D, Lu C, Cheng SY, Ringel MD.

Oncogene. 2011 Oct 20;30(42):4307-15. doi: 10.1038/onc.2011.136. Epub 2011 May 2.

41.

Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate acetate.

Muthusamy N, Breidenbach H, Andritsos L, Flynn J, Jones J, Ramanunni A, Mo X, Jarjoura D, Byrd JC, Heerema NA.

Cancer Genet. 2011 Feb;204(2):77-83. doi: 10.1016/j.cancergen.2010.12.006.

42.

OSU-DY7, a novel D-tyrosinol derivative, mediates cytotoxicity in chronic lymphocytic leukaemia and Burkitt lymphoma through p38 mitogen-activated protein kinase pathway.

Bai LY, Ma Y, Kulp SK, Wang SH, Chiu CF, Frissora F, Mani R, Mo X, Jarjoura D, Byrd JC, Chen CS, Muthusamy N.

Br J Haematol. 2011 Jun;153(5):623-33. doi: 10.1111/j.1365-2141.2010.08443.x. Epub 2011 Apr 7.

43.

The after discharge care management of low income frail elderly (AD-LIFE) randomized trial: theoretical framework and study design.

Allen KR, Hazelett SE, Jarjoura D, Wright K, Fosnight SM, Kropp DJ, Hua K, Pfister EW.

Popul Health Manag. 2011 Jun;14(3):137-42. doi: 10.1089/pop.2010.0016. Epub 2011 Feb 15.

44.

IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production.

Jaime-Ramirez AC, Mundy-Bosse BL, Kondadasula S, Jones NB, Roda JM, Mani A, Parihar R, Karpa V, Papenfuss TL, LaPerle KM, Biller E, Lehman A, Chaudhury AR, Jarjoura D, Burry RW, Carson WE 3rd.

J Immunol. 2011 Mar 15;186(6):3401-9. doi: 10.4049/jimmunol.1000328. Epub 2011 Feb 14.

45.

Effects on survival of menstrual cycle phase of adjuvant surgical oophorectomy in premenopausal women with breast cancer.

Love RR, Young GS, Hade EM, Jarjoura D.

Breast Cancer Res Treat. 2011 Apr;126(2):479-85. doi: 10.1007/s10549-011-1370-0. Epub 2011 Feb 4.

PMID:
21293921
46.

Prevalence of obstructive sleep apnea in patients with chronic wounds.

Patt BT, Jarjoura D, Lambert L, Roy S, Gordillo G, Schlanger R, Sen CK, Khayat RN.

J Clin Sleep Med. 2010 Dec 15;6(6):541-4.

47.

Fully moderated T-statistic for small sample size gene expression arrays.

Yu L, Gulati P, Fernandez S, Pennell M, Kirschner L, Jarjoura D.

Stat Appl Genet Mol Biol. 2011 Sep 15;10(1). pii: /j/sagmb.2011.10.issue-1/1544-6115.1701/1544-6115.1701.xml. doi: 10.2202/1544-6115.1701.

48.

Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition.

Ni W, Ji J, Dai Z, Papp A, Johnson AJ, Ahn S, Farley KL, Lin TS, Dalton JT, Li X, Jarjoura D, Byrd JC, Sadee W, Grever MR, Phelps MA.

PLoS One. 2010 Nov 1;5(11):e13792. doi: 10.1371/journal.pone.0013792.

49.

Epigenetic regulation of beta2-adrenergic receptor expression in T(H)1 and T(H)2 cells.

McAlees JW, Smith LT, Erbe RS, Jarjoura D, Ponzio NM, Sanders VM.

Brain Behav Immun. 2011 Mar;25(3):408-15. doi: 10.1016/j.bbi.2010.10.019. Epub 2010 Nov 1.

50.

Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.

McCarty SK, Saji M, Zhang X, Jarjoura D, Fusco A, Vasko VV, Ringel MD.

Endocr Relat Cancer. 2010 Oct 29;17(4):989-99. doi: 10.1677/ERC-10-0168. Print 2010 Dec.

Supplemental Content

Loading ...
Support Center